康弘药业(002773.SZ)：米拉贝隆缓释片获药品注册证书

Core Viewpoint - Kanghong Pharmaceutical has received the drug registration certificate for Mirabegron extended-release tablets from the National Medical Products Administration, indicating regulatory approval for the product [1] Group 1 - The drug Mirabegron is a selective β3 adrenergic receptor agonist [1] - Mirabegron acts on bladder tissue to relax the smooth muscle of the bladder [1]